Health Care & Life Sciences » Pharmaceuticals | Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1,360
1,903
2,735
10,232
5,944
Total Accounts Receivable
46,731
40,880
38,882
43,671
42,058
Inventories
7,306
9,367
11,157
12,072
13,048
Other Current Assets
1,941
348
608
1,059
97
Total Current Assets
57,338
52,498
53,383
67,035
61,147
Net Property, Plant & Equipment
17,540
21,913
23,268
25,431
24,017
Total Investments and Advances
46,282
46,947
46,658
33,878
33,118
Long-Term Note Receivable
5,065
5,276
5,626
-
-
Intangible Assets
2,878
3,245
2,892
1,747
1,244
Other Assets
1,400
-
-
1,166
1,181
Total Assets
130,972
130,468
132,632
130,721
121,816
ST Debt & Current Portion LT Debt
42,581
38,913
29,117
22,877
32,285
Accounts Payable
3,659
5,133
4,665
5,810
7,904
Income Tax Payable
3,527
1,645
1,790
2,663
2,544
Other Current Liabilities
3,778
4,682
4,890
7,150
7,436
Total Current Liabilities
53,546
50,373
40,463
38,499
50,168
Long-Term Debt
1,452
429
7,742
13,076
12,757
Provision for Risks & Charges
4,271
5,779
7,225
7,943
7,170
Deferred Taxes
470
588
805
1,463
1,108
Other Liabilities
56
-
-
-
-
Total Liabilities
59,325
56,580
55,430
59,518
70,095
Common Equity (Total)
71,647
73,887
77,202
71,203
51,721
Total Shareholders' Equity
71,647
73,887
77,202
71,203
51,721
Total Equity
71,647
73,887
77,202
71,203
51,721
Liabilities & Shareholders' Equity
130,972
130,468
132,632
130,721
121,816

About Daehan New Pharm Co.

View Profile
Address
66 Jeyakgongdan 1-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.dhnp.co.kr
Updated 09/14/2018
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. It operates through the pharmaceutical and animal health product business divisions. The pharmaceutical division provides analgesics anti-inflammatory drugs and antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics and immunosuppressants, cardiovascular drugs, gatrointestinal drugs, muscle relaxants, antispasmodics, cream or ointments and others.